Vivos Therapeutics Inc (VVOS) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Vivos Therapeutics Inc   (NASDAQ: VVOS)

Select the Financial Report: Select the Period:


Description of Vivos Therapeutics Inc's Business Segments


Vivos Therapeutics, Inc. is a company that specializes in innovative treatment solutions for sleep-disordered breathing, primarily focusing on obstructive sleep apnea (OSA) and related conditions. The company leverages a combination of advanced technology, clinical research, and multidisciplinary expertise to develop comprehensive therapeutic options.

Segments

The offerings of Vivos Therapeutics can be divided into several key segments:

1. Medical Devices:
- Vivos develops a range of dental and orthodontic appliances designed to treat sleep-disordered breathing through non-invasive methods. These devices aim to promote the proper alignment of the jaw and airway, which can improve airflow during sleep.
- The flagship product is the Vivos System, which includes a series of appliances that utilize gentle forces to expand the maxilla and mandible, subsequently remodeling the airway.

2. Education and Training:
- Vivos provides educational resources and training programs for healthcare professionals, particularly in dentistry and orthodontics. These programs are designed to teach practitioners about the management of sleep-disordered breathing and the application of Vivos products in clinical practice.
- The company also offers continuing education courses focusing on the integration of Vivos therapy into existing practice frameworks.

3. Consultation and Clinical Support:
- Vivos Therapeutics offers consultation services for healthcare providers who want to implement its solutions in their practices. This can include assistance in the evaluation of patients, treatment planning, and device management.
- The company prides itself on providing ongoing clinical support to practitioners to ensure effective patient outcomes and adherence to best practices.

Products

The primary products offered by Vivos Therapeutics include:

1. Vivos System Applainces:
- Vivos Air: A custom-fit device designed to reposition the tongue and mandible to improve airway space.
- Vivos Tongue Stabilizing Device: A device focused on preventing the tongue from obstructing the airway during sleep.
- Vivos Modus: A device that provides orthopedic and orthodontic intervention to address underlying issues contributing to OSA.

2. Airway Health Solutions:
- Vivos emphasizes airway health through its products that not only address sleep apnea but also promote overall oral and maxillofacial development, especially in children. These solutions aim to create a more optimal airway structure from an early age.

3. Home Monitoring and Diagnostics:
- While primarily focused on treatment, Vivos also engages in efforts related to the monitoring and diagnostic aspects of sleep health. This segment may include collaborations to provide tools for evaluating the efficacy of their treatments in real time.

Services

The services offered by Vivos Therapeutics encompass a range of supportive and clinical functions, including:

1. Patient Management:
- Vivos provides guidance on managing patients with sleep-disordered breathing, assisting practitioners in tracking treatment progress and addressing any complications that arise.

2. Telehealth Support:
- Recognizing the growing trend in telehealth, Vivos may offer virtual consultations and remote support for healthcare providers to enhance patient care and maintain ongoing interactions with patients undergoing treatment.

3. Clinical Research Initiatives:
- Vivos is involved in clinical research to validate the efficacy of its treatments, and may collaborate with universities and research institutions to further the understanding of sleep-disordered breathing management.

Overall, Vivos Therapeutics, Inc. focuses on providing innovative treatment options, comprehensive training for healthcare providers, and ongoing clinical support to improve the management of sleep-disordered breathing, positioning itself as a leader in this niche market. The companys holistic approach prioritizes not only symptom relief but also long-term airway health and the overall well-being of patients.


Composition of Vivos Therapeutics Inc Revenues by Segments

 
Product    54.24 % of total Revenue
Service    145.53 % of total Revenue
Treatment Centers    20.63 % of total Revenue
Sleep Testing Services    32.21 % of total Revenue
Sponsorship Seminar Other    7.1 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Product 2.80 54.24 %
Service 7.50 145.53 %
Treatment Centers 1.06 20.63 %
Sleep Testing Services 1.66 32.21 %
Sponsorship Seminar Other 0.37 7.1 %
Total 5.15 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Product - 94.1 %
Service - 102.62 %
Treatment Centers - 19.17 %
Sleep Testing Services - -27.7 %
Sponsorship Seminar Other - 78.54 %
Total 65.69 % 1.86 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -5.52 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Vivos Therapeutics Inc Divisions, Sales by Country

 
Product   Product Segment contribution to total sales 39.22 % of total Revenue
Service   Service Segment contribution to total sales 66.23 % of total Revenue
Treatment Centers   Treatment Centers Segment contribution to total sales 13.17 % of total Revenue
Sleep Testing Services   Sleep Testing Services Segment contribution to total sales 36.52 % of total Revenue
Sponsorship Seminar Other   Sponsorship Seminar Other Segment contribution to total sales 7.39 % of total Revenue
Appliances   Appliances Segment contribution to total sales 19.81 % of total Revenue
Tooth Positioners   Tooth Positioners Segment contribution to total sales 19.41 % of total Revenue
VIP   VIP Segment contribution to total sales 2.97 % of total Revenue
Billing Intelligence Services   Billing Intelligence Services Segment contribution to total sales 4.15 % of total Revenue
Myofunctional Therapy Services   Myofunctional Therapy Services Segment contribution to total sales 2.04 % of total Revenue


Twelve months ended 2025
VVOS s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Product 6.49 39.22 %
Service 10.96 66.23 %
Treatment Centers 2.18 13.17 %
Sleep Testing Services 6.04 36.52 %
Sponsorship Seminar Other 1.22 7.39 %
Total 16.54 100 %
Appliances 3.28 19.81 %
Tooth Positioners 3.21 19.41 %
VIP 0.49 2.97 %
Billing Intelligence Services 0.69 4.15 %
Myofunctional Therapy Services 0.34 2.04 %


Twelve months ended 2025
VVOS s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -21.23 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Product -17.61 % -
Service 53.08 % -
Sleep Testing Services 371.22 % -
Sponsorship Seminar Other -37.04 % -
Total 10.14 % -
Appliances -41.49 % -
Tooth Positioners 41.22 % -
VIP -80.24 % -
Billing Intelligence Services -18.33 % -
Myofunctional Therapy Services -44.66 % -
Guides - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.